Ratnatris Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2005.
2005 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Ratnatris Pharmaceuticals Private Limited

Ratnatris Pharmaceuticals Private Limited, a active private limited company, was established on 29 December 2005 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2005PTC047394. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹3.74 Cr.

Formerly known as Inteligence Pharmaceuticals Private Limited, Ratnamani Healthcare Private Limited. It upholds a compliant status. Employing 369 professional, Its leadership includes Swapnil Jatinbhai Shah (Director), Chetan Bipinchandra Shah (Director), Kalpit Rajesh Gandhi (Director). Past directors included Chandraprakash Pukhraj Bhansali, Sanjaykumar Jitendrabhai Jha, Sunil Vashdev Gvalani. It holds ₹125.50 Cr open charges and ₹10.25 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1004-1006, 10Th Floor, North Tower, One42, Off. Bopal Ambli Road, Opp. Ashok Vatika, Bod, Akdev, Ahmedabad, Gujarat, 380054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2005PTC047394

  • Registration Number

    047394

  • Incorporation Date

    29 December 2005

  • Authorized Capital

    ₹4.50 Cr

  • Paid-Up Capital

    ₹3.74 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.50 Cr
  • Paid Up Capital ₹ 3.74 Cr
  • Company Age 20 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 125.50 Cr
  • Satisfied Charges ₹ 10.25 Cr
  • Revenue Growth **** 48.41%
  • Profit Growth **** 81.41%
  • Ebitda **** 237.03%
  • Net Worth -11.83%
  • Total Assets **** 4.14%
Company report

Ratnatris Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ratnatris Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ratnatris Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Swapnil Jatinbhai Shah Director 15 Jan 2021 Current
Chetan Bipinchandra Shah Director 14 May 2025 Current
Kalpit Rajesh Gandhi Director 12 Jun 2024 Current
Udayan Dileep Choksi Director 12 Jun 2024 Current
Jitendra Babulal Sanghvi Director 11 Aug 2009 Current
Arpit Deepakkumar Shah Director 15 Jan 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 25 Jan 2010 Past
Pramod Abcsdd Additional Director 30 Sep 2021 Past
Pramod Abcsdd Director 18 Aug 2015 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ratnatris Pharmaceuticals.

Ratnatris Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.41% increase. The company also saw a substantial improvement in profitability, with a 81.41% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.83%.

Ratnatris Pharmaceuticals revenue growth over time
Ratnatris Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 48.41%
*******
*******
*******
*******
Revenue from Operations
*******
 44.54%
*******
*******
*******
*******
Total Assets
*******
 4.14%
*******
*******
*******
*******
Profit or Loss
*******
 81.41%
*******
*******
*******
*******
Net Worth
*******
 -11.83%
*******
*******
*******
*******
EBITDA
*******
 237.03%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ratnatris Pharmaceuticals?

In 2024, Ratnatris Pharmaceuticals had a promoter holding of 95.34% and a public holding of 4.66%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,255,000,261.00

Satisfied Charges

₹102,500,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 125.50 Cr
Latest Charge Details
Date Lender Amount Status
30 Jun 2023 Hdfc Bank Limited ₹2.20 M Open
23 Jun 2023 Hdfc Bank Limited ₹81.20 Cr Open
09 Sep 2022 Hdfc Bank Limited ₹8.00 M Open
08 Dec 2015 Hdfc Bank Limited ₹43.28 Cr Open
17 Jan 2013 Union Bank Of India ₹5.40 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ratnatris Pharmaceuticals?

Ratnatris Pharmaceuticals has a workforce of 369 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ratnatris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ratnatris Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ratnatris Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Ratnatris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 81.20 Cr registered on 23 Jun 2023 with Charge ID 100762761 was modified on 17 Jul 2025. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 43.28 Cr registered on 08 Dec 2015 with Charge ID 10609443 was modified on 24 Jun 2025. was documented.

  • Director Appointment

    Chetan Bipinchandra Shah was appointed as a Director was appointed as a Director on 14 May 2025 & has been associated with this company since 9 months 11 days . was recorded as a recent event.

  • Balance Sheet

    Ratnatris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    Kalpit Rajesh Gandhi was appointed as a Director was appointed as a Director on 12 Jun 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ratnatris Pharmaceuticals Private Limited?

The CIN of Ratnatris Pharmaceuticals Private Limited is U24230GJ2005PTC047394.

Where is Ratnatris Pharmaceuticals Private Limited headquartered?

Ratnatris Pharmaceuticals Private Limited is headquartered at 1004-1006, 10Th Floor, North Tower, One42, Off. Bopal Ambli Road, Opp. Ashok Vatika, Bod, Akdev, Ahmedabad, Gujarat, 380054.

When was Ratnatris Pharmaceuticals Private Limited incorporated?

Ratnatris Pharmaceuticals Private Limited was incorporated on 29 December 2005.

Who are the current directors of Ratnatris Pharmaceuticals Private Limited?

The current directors of Ratnatris Pharmaceuticals Private Limited are

What is the primary industry of Ratnatris Pharmaceuticals Private Limited?

The primary industry of Ratnatris Pharmaceuticals Private Limited is Manufacturing.

Is Ratnatris Pharmaceuticals Private Limited a listed company?

Ratnatris Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Ratnatris Pharmaceuticals Private Limited?

The authorized capital of Ratnatris Pharmaceuticals Private Limited is ₹4.50 Cr, and the paid-up capital is ₹3.74 Cr.

What is the compliance status of Ratnatris Pharmaceuticals Private Limited?

The compliance status of Ratnatris Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available